GTBP · GT Biopharma, Inc. · Investor Relations
$6.10
-0.10 (-1.61%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year of the date that the financial statements are issued. In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2025 financial statements, raised substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$12.43M
Shares
1.80M
Volume · Oct 2
62.62K
Avg daily vol (18 sessions)
134.62K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-11 | WEBINAR: THE TRIKE PLATFORM, CLINICAL PROGRESS, AND THE CASE FOR NK CELL IMMUNOTHERAPY | Webcast |
| 2026-08-14 | ANNUAL MEETING OF STOCKHOLDERS | Shareholder meeting |
| 2026-03-24 | 38TH ANNUAL ROTH CONFERENCE | Conference |
| 2026-03-05 | CENTURION ONE CAPITAL 9TH ANNUAL TORONTO GROWTH CONFERENCE | Conference |
Source: https://ir.gtbiopharma.com/